Vancouver, Wash. biotech company Absci files to go public
GeekWire
JUNE 30, 2021
The company, founded in 2011, began commercial operations in 2018 and now has partnerships with Merck, Xyphos Biotechnology, Alpha Cancer Technologies and several other drug companies. Net losses were $14.4 Securities and Exchange Commission. 2020 revenue was $4.7 million, up from $2 million for 2019. 2020 revenue was $4.7
Let's personalize your content